Raptor Pharmaceutical to Present at Leerink Swann Rare Disease Roundtable
September 26, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced management will present at the Leerink Swann Rare Disease Roundtable in New York on October...
Raptor Pharmaceutical Receives Marketing Authorization for PROCYSBI(R) in European Union
September 12, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the European Commission (EC) has approved PROCYSBI® gastro-resistant hard...
Raptor Pharmaceutical Announces Presentation at the International Pediatric Nephrology Association Meeting in Shanghai
August 29, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 29, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that PROCYSBI (cysteamine bitartrate) will be featured in an upcoming presentation at the...
Raptor Pharmaceutical Provides PROCYSBI(TM) Launch Update and Second Quarter 2013 Financial Results
August 08, 2013 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided a launch update for PROCYSBI (cysteamine bitartrate) delayed-release capsules and financial...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
August 06, 2013 07:29 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Julie Anne Smith, Raptor's Executive Vice President, Strategy and Chief Operating...
Raptor Pharmaceutical to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 8, 2013
August 01, 2013 07:29 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2013 financial results after market close on Thursday,...
PROCYSBI(R) Receives Positive Opinion for Orphan Drug Exclusivity From the EU Committee for Orphan Medicinal Products
July 22, 2013 07:00 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has received a positive opinion from the European Union (EU) Committee for Orphan...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
July 02, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor's CEO, will present an overview of the company at...
Raptor's PROCYSBI(TM) Receives U.S. Orphan Drug Exclusivity
June 25, 2013 16:05 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 25, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Office of Orphan Product Development at the Food and Drug Administration (FDA)...
Raptor Pharmaceutical to Present at Upcoming Investor Conference
June 12, 2013 07:30 ET
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Julie Anne Smith, executive vice president, strategy and chief operating officer of...